Here we show that normal ABL1 kinase plays a tumor suppressor role in hematological malignancies induced by AML1-ETO and NUP98-PMX1 and modulates the response to phosphatidylinositol-3 kinase (PI3K) and DNA damage response (DDR) inhibitors. Here, RUNX1T1 is linked to hematologic disorder.